Misoprostol vaginal insert

Drug Profile

Misoprostol vaginal insert

Alternative Names: Misodel; Misopess; Misoprostol CR insert; MVI 100; Mysodelle; Myspess; XP 16J

Latest Information Update: 30 Sep 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cytokine PharmaSciences
  • Developer Cytokine PharmaSciences; Ferring Pharmaceuticals
  • Class Abortifacients; Antiulcers; Oxytocics; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Labour induction

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 09 May 2016 Launched for Labour induction in Israel (Vaginal) before May 2016
  • 09 Sep 2015 No recent reports on development identified - Phase-III for Labour induction in Canada (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top